1107 related articles for article (PubMed ID: 21512031)
21. Hippo signaling interactions with Wnt/β-catenin and Notch signaling repress liver tumorigenesis.
Kim W; Khan SK; Gvozdenovic-Jeremic J; Kim Y; Dahlman J; Kim H; Park O; Ishitani T; Jho EH; Gao B; Yang Y
J Clin Invest; 2017 Jan; 127(1):137-152. PubMed ID: 27869648
[TBL] [Abstract][Full Text] [Related]
22. Pitx2 promotes heart repair by activating the antioxidant response after cardiac injury.
Tao G; Kahr PC; Morikawa Y; Zhang M; Rahmani M; Heallen TR; Li L; Sun Z; Olson EN; Amendt BA; Martin JF
Nature; 2016 Jun; 534(7605):119-23. PubMed ID: 27251288
[TBL] [Abstract][Full Text] [Related]
23. Hippo signaling promotes lung epithelial lineage commitment by curbing Fgf10 and β-catenin signaling.
Volckaert T; Yuan T; Yuan J; Boateng E; Hopkins S; Zhang JS; Thannickal VJ; Fässler R; De Langhe SP
Development; 2019 Jan; 146(2):. PubMed ID: 30651296
[TBL] [Abstract][Full Text] [Related]
24. E-cadherin mediates contact inhibition of proliferation through Hippo signaling-pathway components.
Kim NG; Koh E; Chen X; Gumbiner BM
Proc Natl Acad Sci U S A; 2011 Jul; 108(29):11930-5. PubMed ID: 21730131
[TBL] [Abstract][Full Text] [Related]
25. Deregulation of the Hippo pathway in mouse mammary stem cells promotes mammary tumorigenesis.
Li H; Gumbiner BM
Mamm Genome; 2016 Dec; 27(11-12):556-564. PubMed ID: 27601049
[TBL] [Abstract][Full Text] [Related]
26. Regulation of Myocardial Cell Growth and Death by the Hippo Pathway.
Ikeda S; Sadoshima J
Circ J; 2016 Jun; 80(7):1511-9. PubMed ID: 27302848
[TBL] [Abstract][Full Text] [Related]
27. The Hippo signal transduction network in skeletal and cardiac muscle.
Wackerhage H; Del Re DP; Judson RN; Sudol M; Sadoshima J
Sci Signal; 2014 Aug; 7(337):re4. PubMed ID: 25097035
[TBL] [Abstract][Full Text] [Related]
28. RHOA activity in expanding blastocysts is essential to regulate HIPPO-YAP signaling and to maintain the trophectoderm-specific gene expression program in a ROCK/actin filament-independent manner.
Marikawa Y; Alarcon VB
Mol Hum Reprod; 2019 Feb; 25(2):43-60. PubMed ID: 30395288
[TBL] [Abstract][Full Text] [Related]
29. Genome-wide analysis of N1ICD/RBPJ targets in vivo reveals direct transcriptional regulation of Wnt, SHH, and hippo pathway effectors by Notch1.
Li Y; Hibbs MA; Gard AL; Shylo NA; Yun K
Stem Cells; 2012 Apr; 30(4):741-52. PubMed ID: 22232070
[TBL] [Abstract][Full Text] [Related]
30. Lats2 modulates adipocyte proliferation and differentiation via hippo signaling.
An Y; Kang Q; Zhao Y; Hu X; Li N
PLoS One; 2013; 8(8):e72042. PubMed ID: 23977200
[TBL] [Abstract][Full Text] [Related]
31. β-Catenin destruction complex-independent regulation of Hippo-YAP signaling by APC in intestinal tumorigenesis.
Cai J; Maitra A; Anders RA; Taketo MM; Pan D
Genes Dev; 2015 Jul; 29(14):1493-506. PubMed ID: 26193883
[TBL] [Abstract][Full Text] [Related]
32. LncRNA MALAT1/miR-181a-5p affects the proliferation and adhesion of myeloma cells via regulation of Hippo-YAP signaling pathway.
Sun Y; Jiang T; Jia Y; Zou J; Wang X; Gu W
Cell Cycle; 2019 Oct; 18(19):2509-2523. PubMed ID: 31397203
[TBL] [Abstract][Full Text] [Related]
33. [Crosstalk of Hippo/YAP and Wnt/β-catenin pathways].
Xu F; Zhang J; Ma D
Yi Chuan; 2014 Feb; 36(2):95-102. PubMed ID: 24846937
[TBL] [Abstract][Full Text] [Related]
34. The peptide mimicking small extracellular ring domain of CD82 inhibits epithelial-mesenchymal transition by downregulating Wnt pathway and upregulating hippo pathway.
He X; Huang X; Wang C; Luan M; Li Y; Ma X; Ma K
Biochem Biophys Res Commun; 2020 Dec; 533(3):338-345. PubMed ID: 32958256
[TBL] [Abstract][Full Text] [Related]
35. The Hippo pathway in the heart: pivotal roles in development, disease, and regeneration.
Wang J; Liu S; Heallen T; Martin JF
Nat Rev Cardiol; 2018 Nov; 15(11):672-684. PubMed ID: 30111784
[TBL] [Abstract][Full Text] [Related]
36. Wnt signaling promotes androgen-independent prostate cancer cell proliferation through up-regulation of the hippo pathway effector YAP.
Seo WI; Park S; Gwak J; Ju BG; Chung JI; Kang PM; Oh S
Biochem Biophys Res Commun; 2017 May; 486(4):1034-1039. PubMed ID: 28366633
[TBL] [Abstract][Full Text] [Related]
37. miR-206 Mediates YAP-Induced Cardiac Hypertrophy and Survival.
Yang Y; Del Re DP; Nakano N; Sciarretta S; Zhai P; Park J; Sayed D; Shirakabe A; Matsushima S; Park Y; Tian B; Abdellatif M; Sadoshima J
Circ Res; 2015 Oct; 117(10):891-904. PubMed ID: 26333362
[TBL] [Abstract][Full Text] [Related]
38. A molecular mechanism that links Hippo signalling to the inhibition of Wnt/β-catenin signalling.
Imajo M; Miyatake K; Iimura A; Miyamoto A; Nishida E
EMBO J; 2012 Mar; 31(5):1109-22. PubMed ID: 22234184
[TBL] [Abstract][Full Text] [Related]
39. RAC-LATS1/2 signaling regulates YAP activity by switching between the YAP-binding partners TEAD4 and RUNX3.
Jang JW; Kim MK; Lee YS; Lee JW; Kim DM; Song SH; Lee JY; Choi BY; Min B; Chi XZ; Bae SC
Oncogene; 2017 Feb; 36(7):999-1011. PubMed ID: 27425596
[TBL] [Abstract][Full Text] [Related]
40. KCTD11 inhibits progression of lung cancer by binding to β-catenin to regulate the activity of the Wnt and Hippo pathways.
Yang M; Han YM; Han Q; Rong XZ; Liu XF; Ln XY
J Cell Mol Med; 2021 Oct; 25(19):9411-9426. PubMed ID: 34453479
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
